SLT as primary therapy for POAG

Article

Effective at lowering pressure and repeatability make SLT first choice

Selective laser trabeculoplasty (SLT) has been applied in clinical practice since 2001. Before that time, the only laser surgery available to us that we could use in the chamber angle was argon laser trabeculoplasty (ALT). Compared with ALT, SLT is much better for the trabecular meshwork tissue and it has now completely eradicated the use of ALT. A number of studies in the literature comparing the two methods have demonstrated this.1

Fast, safe and effective method

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
3 experts are featured in this series.
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.